Several analysts have recently updated their ratings and price targets for Insmed (NASDAQ: INSM): 6/7/2024 – Insmed had its price target raised by analysts at Mizuho from $36.00 to $82.00. They now have a “buy” rating on the stock. 5/31/2024 – Insmed had its price target raised by analysts at Stifel Nicolaus from $39.00 to […]
Scout Investments Inc. lowered its holdings in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 293,197 shares of the biopharmaceutical company’s stock after selling 4,600 shares during the period. Scout Investments Inc. owned about 0.20% […]
Insmed Incorporated (NASDAQ:INSM – Get Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 9,930,000 shares, a growth of 16.4% from the April 30th total of 8,530,000 shares. Based on an average daily volume of 1,760,000 shares, the […]
Insmed (NASDAQ:INSM – Get Free Report) had its price objective hoisted by equities research analysts at HC Wainwright from $52.00 to $70.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price objective would indicate a potential upside of 22.85% from the […]
Wells Fargo & Company reissued their overweight rating on shares of Insmed (NASDAQ:INSM – Free Report) in a report released on Monday morning, Benzinga reports. The brokerage currently has a $55.00 price objective on the biopharmaceutical company’s stock. Several other brokerages have also issued reports on INSM. Wolfe Research started coverage on shares of Insmed […]